Rolandsdotter, H.; Marits, P.; Sundin, U.; Wikström, A.-C.; Fagerberg, U.L.; Finkel, Y.; Eberhardson, M.
Serum-Infliximab Trough Levels in 45 Children with Inflammatory Bowel Disease on Maintenance Treatment. Int. J. Mol. Sci. 2017, 18, 575.
https://doi.org/10.3390/ijms18030575
AMA Style
Rolandsdotter H, Marits P, Sundin U, Wikström A-C, Fagerberg UL, Finkel Y, Eberhardson M.
Serum-Infliximab Trough Levels in 45 Children with Inflammatory Bowel Disease on Maintenance Treatment. International Journal of Molecular Sciences. 2017; 18(3):575.
https://doi.org/10.3390/ijms18030575
Chicago/Turabian Style
Rolandsdotter, Helena, Per Marits, Ulf Sundin, Ann-Charlotte Wikström, Ulrika L. Fagerberg, Yigael Finkel, and Michael Eberhardson.
2017. "Serum-Infliximab Trough Levels in 45 Children with Inflammatory Bowel Disease on Maintenance Treatment" International Journal of Molecular Sciences 18, no. 3: 575.
https://doi.org/10.3390/ijms18030575
APA Style
Rolandsdotter, H., Marits, P., Sundin, U., Wikström, A.-C., Fagerberg, U. L., Finkel, Y., & Eberhardson, M.
(2017). Serum-Infliximab Trough Levels in 45 Children with Inflammatory Bowel Disease on Maintenance Treatment. International Journal of Molecular Sciences, 18(3), 575.
https://doi.org/10.3390/ijms18030575